ArticleBMC nephrology2026

C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report.

Hiroki Yanagidani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.